Into This World We're Thrown
NCT05406167
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Drug Category: Other
Gender: All
Age: Child, Adult, Older Adult
Location of Metastases: Brain, Bone
Additional Notes:
Exclusions:
https://ClinicalTrials.gov/show/NCT05406167
NCT05351294
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 3
Drug Category: Other
Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain, Bone, Liver
Additional Notes: Patients must be planning, or actively receiving, systemic therapy (e.g. chemotherapy, targeted/biologic therapy, immunotherapy, or hormonal therapy)
Exclusions: Patients who are responsive to hormonal therapy; Patients with history of whole brain radiation therapy for brain metastases (patients who underwent one prior treatment with radiosurgery for brain metastases are eligible)
https://ClinicalTrials.gov/show/NCT05351294